Elixxer Ltd - Asset Resilience Ratio

Latest as of December 2023: 0.00%

Elixxer Ltd (ELXR) has an Asset Resilience Ratio of 0.00% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Elixxer Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CA$0.00

≈ $0.00 USD Cash + Short-term Investments

Total Assets

CA$2.81 Million

≈ $2.03 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2017–2023)

This chart shows how Elixxer Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Elixxer Ltd (ELXR) total assets.

Liquid Assets Composition Over Time

This chart breaks down Elixxer Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Elixxer Ltd (ELXR) investment intensity to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CA$0.00	0%
Short-term Investments	CA$0.00	0%
Total Liquid Assets	CA$0.00	0.00%

Asset Resilience Insights

Limited Liquidity: Elixxer Ltd maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company maintains a balanced mix of cash and short-term investments.

Elixxer Ltd Industry Peers by Asset Resilience Ratio

Compare Elixxer Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Beijing Tongrentang Co Ltd SHG:600085	Drug Manufacturers - Specialty & Generic	0.50%
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Neuland Laboratories Limited NSE:NEULANDLAB	Drug Manufacturers - Specialty & Generic	9.65%
China Resources Double-Crane Pharmaceutical Co Ltd SHG:600062	Drug Manufacturers - Specialty & Generic	1.18%
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	Drug Manufacturers - Specialty & Generic	0.01%

Annual Asset Resilience Ratio for Elixxer Ltd (2017–2023)

The table below shows the annual Asset Resilience Ratio data for Elixxer Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	0.00%	CA$0.00 ≈ $0.00	CA$2.81 Million ≈ $2.03 Million	--
2022-12-31	44.82%	CA$2.41 Million ≈ $1.74 Million	CA$5.37 Million ≈ $3.88 Million	-34.09pp
2021-12-31	78.91%	CA$13.28 Million ≈ $9.61 Million	CA$16.84 Million ≈ $12.18 Million	--
2020-12-31	0.00%	CA$0.00 ≈ $0.00	CA$20.81 Million ≈ $15.06 Million	--
2018-12-31	0.00%	CA$0.00 ≈ $0.00	CA$20.74 Million ≈ $15.00 Million	--
2017-12-31	24.65%	CA$677.24K ≈ $489.91K	CA$2.75 Million ≈ $1.99 Million	--

pp = percentage points

About Elixxer Ltd

V:ELXR Canada Drug Manufacturers - Specialty & Generic

Market Cap

$287.08K

CA$396.86K CAD

Market Cap Rank

#31244 Global

#1668 in Canada

Share Price

CA$0.04

Change (1 day)

+0.00%

52-Week Range

CA$0.03 - CA$1.15

All Time High

CA$99.00